Tier 2 Canada Research Chair in Microbiota and Host-Microbe Interactions
The Faculty of Health Sciences (FHS) at Queen’s University invites applications from exceptional scholars in the area of microbiota and host-microbe interactions. This appointment is open only to qualified individuals who self-identify as women1. We welcome and support applications from such candidates who also identify as members of other equity-deserving groups, i.e. Indigenous/Aboriginal peoples, persons with disabilities, racialized/visible minorities, and members of 2SLGBTQ+ communities. The successful candidate will be appointed at the rank of Assistant or Associate Professor, depending upon level of experience, in the Department of Biomedical and Molecular Sciences with an anticipated start date of July 1, 2022. They will be expected to submit an external nomination for a five-year term position as a Tier 2 Canada Research Chair (CRC), eligible for renewal once, to a maximum of two five-year terms as a Tier 2 CRC in Microbiota and Host-Microbe Interactions.
Postdoctoral Fellow: Drs. Postovit (Queen's University, Canada), Larsson (Karolinska Institute, Sweden), and Topisirovic (LDI/McGill University, Canada)
Applications are solicited for a Postdoctoral fellow position focusing on a collaborative efforts initiated between the Postovit (Queen’s University, Kingston, Canada), Larsson (Karolinska Institute, Stockholm, Sweden) and Topisirovic (McGill University, Montreal, Canada) labs that are focused on understanding the mechanisms that underpin plasticity of cancer cells and their ability to adapt to stressors emanating from their environment (e.g., hypoxia) and therapeutic insults (e.g., chemotherapeutics). More specifically, we are looking for a candidate who is interested in joining a team with broad and complementary expertise (e.g., systems biology, developmental, molecular, cellular biology and bioinformatics) whose major goal is to dissect the mechanisms that orchestrate epigenetic, translational and metabolic programs in context of
cancer cell plasticity using state-of-the-art cell line-based and in vivo models. To this end, the candidate will be exposed to a multidisciplinary training program comprising a variety of well-established molecular, cell biology and biochemical techniques as well as newly developed systems biology (epigenomics, translatomics, metabolomics) and associated bioinformatic approaches.